Cargando…
A Randomized Prospective Non-Inferiority Trial of Sentinel Lymph Node Biopsy in Early Breast Cancer: Blue Dye Compared with Indocyanine Green Fluorescence Tracer
SIMPLE SUMMARY: This randomized study was conducted to evaluate sentinel lymph node biopsy with indocyanine green (ICG) compared with blue dye as a tracer in women with early breast cancer without any sign of lymph node invasion. ICG is a fluorescent tracer well known in medical practice for 50 year...
Autores principales: | Coibion, Michel, Olivier, Fabrice, Courtois, Audrey, Maes, Nathalie, Jossa, Véronique, Jerusalem, Guy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870473/ https://www.ncbi.nlm.nih.gov/pubmed/35205636 http://dx.doi.org/10.3390/cancers14040888 |
Ejemplares similares
-
Application of fluorescence endoscopy with methylene blue dye and indocyanine green dual-tracer method in sentinel lymph node biopsy for women with breast cancer
por: Ou, Caifeng, et al.
Publicado: (2023) -
ASO Author Reflections: Comparison of Indocyanine Green with Blue Dye in Sentinel Lymph Node Biopsy for Cutaneous Melanoma
por: Fadel, Michael G., et al.
Publicado: (2023) -
Indocyanine Green Lymphangiography: An Alternative to Blue Dye Detection for Sentinel Lymph Node Biopsy in Cutaneous Malignancies of the Head and Neck
por: Parham, Christopher S., et al.
Publicado: (2019) -
ASO Author Reflections: Indocyanine Green Fluorescence Sentinel Lymph Node Biopsy in Breast Cancer—An Alternative to Blue Dye?
por: Nguyen, Chu Luan, et al.
Publicado: (2023) -
Evaluation of the benefit of using blue dye in addition to indocyanine green fluorescence for sentinel lymph node biopsy in patients with breast cancer
por: Guo, Wenbin, et al.
Publicado: (2014)